Medicus Pharma Ltd. (NasdaqCM: MDCX)
Health Care · Biotechnology · US
$3.25
0.00% today · -97.4% 1Y
Medicus Pharma Ltd. (NasdaqCM: MDCX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.11M and employs 16 people.
Over the last twelve months the share price has lost 97.4%, trading between 2.92 and 139.00.
Tweenvest scores Medicus Pharma Ltd. across four factors: quality 24/100, value 26/100. Its strongest factor is value.
MDCX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.11M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -82.98
- Dividend yield
- —
- Beta (5Y)
- -0.30
- 52-week high
- $139.00
- 52-week low
- $2.92
- Avg volume (3M)
- —
- Shares outstanding
- 1.26M
- Employees
- 16
- Next earnings
- —
About Medicus Pharma Ltd.
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
- ISIN
- CA58471K2020
- Founded
- 2008
- Listed since
- Nov 15, 2024
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kane Biotech Inc.TSXV: KNE | $4.33M | CA$0.03 | -16.67% |
| NuCana plcNasdaqCM: NCNA | $4.27M | $0.99 | -9.99% |
| Telo Genomics Corp.TSXV: TELO | $4.26M | CA$0.06 | -14.29% |
| Strategic Partners A/SCPSE: STRAP | $4.11M | Dkr655.00 | -2.96% |
| Liminatus Pharma, Inc.NasdaqCM: LIMN | $4.08M | $3.04 | -19.15% |
| Enlivex Ltd.NasdaqCM: ENLV | $4.08M | $0.21 | -19.29% |
| Biotron LimitedASX: BIT | $3.88M | AU$0.00 | -20.00% |
| Genetic Analysis ASXSAT: GEAN | $3.82M | Nkr— | — |
Figures last refreshed Oct 18, 2026.